Linfomas
GLUN
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (18)
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2020
-
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL
Leukemia, Vol. 34, Núm. 10, pp. 2722-2735
2017
2012
-
Impacto clínico de la cuantificación de la carga mutacional de JAK2V617F en pacientes con neoplasias mieloproliferativas crónicas Ph negativas clásicas
Medicina Clinica, Vol. 139, Núm. 9, pp. 373-378
-
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
Leukemia, Vol. 26, Núm. 7, pp. 1517-1526
-
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
Leukemia and Lymphoma, Vol. 53, Núm. 5, pp. 812-819
2011
-
A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma
Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 30, pp. 12461-12466
-
Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas
PLoS ONE, Vol. 6, Núm. 9
-
PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma
Blood, Vol. 118, Núm. 20, pp. 5517-5527
2010
-
Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
Blood, Vol. 116, Núm. 8
2007
-
Generation of a new monoclonal antibody against MALT1 by genetic immunization
Hybridoma, Vol. 26, Núm. 2, pp. 86-91
-
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Blood, Vol. 109, Núm. 1, pp. 271-280
2005
-
Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas
Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423
2003
-
Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study
Leukemia, Vol. 17, Núm. 10, pp. 2016-2024
-
Genomic abnormalities acquired in the blastic transformation of splenic marginal zone B-cell lymphoma
Leukemia and Lymphoma, Vol. 44, Núm. 3, pp. 459-464
-
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
Blood, Vol. 101, Núm. 10, pp. 4042-4046
-
The Molecular Signature of Mantle Cell Lymphoma Reveals Multiple Signals Favoring Cell Survival
Cancer Research, Vol. 63, Núm. 23, pp. 8226-8232